Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

Articles published in
Oncogene
    July 2021
  1. WHATELY KM, Voronkova MA, Maskey A, Gandhi J, et al
    Nuclear Aurora-A kinase-induced hypoxia signaling drives early dissemination and metastasis in breast cancer: implications for detection of metastatic tumors.
    Oncogene. 2021 Jul 29. pii: 10.1038/s41388-021-01969.
    >> Share

  2. SETO-TETSUO F, Arioka M, Miura K, Inoue T, et al
    DIF-1 inhibits growth and metastasis of triple-negative breast cancer through AMPK-mediated inhibition of the mTORC1-S6K signaling pathway.
    Oncogene. 2021 Jul 24. pii: 10.1038/s41388-021-01958.
    >> Share

  3. ZHANG Y, Shi G, Zhang H, Xiong Q, et al
    Dexamethasone enhances the lung metastasis of breast cancer via a PI3K-SGK1-CTGF pathway.
    Oncogene. 2021 Jul 16. pii: 10.1038/s41388-021-01944.
    >> Share

  4. CLEMENTS ME, Holtslander L, Edwards C, Todd V, et al
    HDAC inhibitors induce LIFR expression and promote a dormancy phenotype in breast cancer.
    Oncogene. 2021 Jul 10. pii: 10.1038/s41388-021-01931.
    >> Share

  5. YU P, Zhu X, Zhu JL, Han YB, et al
    The Chk2-PKM2 axis promotes metabolic control of vasculogenic mimicry formation in p53-mutated triple-negative breast cancer.
    Oncogene. 2021 Jul 9. pii: 10.1038/s41388-021-01933.
    >> Share

  6. HAMALIAN S, Guth R, Runa F, Sanchez F, et al
    A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for antiapoptotic and stress signaling markers.
    Oncogene. 2021 Jul 8. pii: 10.1038/s41388-021-01906.
    >> Share

    June 2021
  7. QIU Y, Yang Y, Yang R, Liu C, et al
    Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer.
    Oncogene. 2021 Jun 25. pii: 10.1038/s41388-021-01896.
    >> Share

  8. BI X, Lou P, Song Y, Sheng X, et al
    Msi1 promotes breast cancer metastasis by regulating invadopodia-mediated extracellular matrix degradation via the Timp3-Mmp9 pathway.
    Oncogene. 2021 Jun 21. pii: 10.1038/s41388-021-01873.
    >> Share

  9. SHARIATI M, Evans KW, Zheng X, Bristow CA, et al
    Combined inhibition of DDR1 and CDK4/6 induces synergistic effects in ER-positive, HER2-negative breast cancer with PIK3CA/AKT1 mutations.
    Oncogene. 2021 Jun 9. pii: 10.1038/s41388-021-01819.
    >> Share

  10. TRUONG TH, Benner EA, Hagen KM, Temiz NA, et al
    PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER(+) breast cancer.
    Oncogene. 2021 Jun 8. pii: 10.1038/s41388-021-01871.
    >> Share

  11. QIAO Y, Jin T, Guan S, Cheng S, et al
    Long non-coding RNA Lnc-408 promotes invasion and metastasis of breast cancer cell by regulating LIMK1.
    Oncogene. 2021 Jun 2. pii: 10.1038/s41388-021-01845.
    >> Share

    May 2021
  12. LODILLINSKY C, Fuhrmann L, Irondelle M, Pylypenko O, et al
    Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance.
    Oncogene. 2021 May 19. pii: 10.1038/s41388-021-01826.
    >> Share

  13. XU Q, Zhang J, Telfer BA, Zhang H, et al
    The extracellular-regulated protein kinase 5 (ERK5) enhances metastatic burden in triple-negative breast cancer through focal adhesion protein kinase (FAK)-mediated regulation of cell adhesion.
    Oncogene. 2021 May 12. pii: 10.1038/s41388-021-01798.
    >> Share

  14. LAGER TW, Conner C, Keating CR, Warshaw JN, et al
    Cell surface GRP78 and Dermcidin cooperate to regulate breast cancer cell migration through Wnt signaling.
    Oncogene. 2021 May 12. pii: 10.1038/s41388-021-01821.
    >> Share

  15. WILLIAMS CB, Phelps-Polirer K, Dingle IP, Williams CJ, et al
    Correction: HUNK phosphorylates EGFR to regulate breast cancer metastasis.
    Oncogene. 2021 May 6. pii: 10.1038/s41388-021-01797.
    >> Share

  16. STEBBING J, Zhang H, Xu Y, Lit LC, et al
    Correction: KSR1 regulates BRCA1 degradation and inhibits breast cancer growth.
    Oncogene. 2021 May 4. pii: 10.1038/s41388-021-01794.
    >> Share

    April 2021
  17. LIU L, Zhang X, Ding H, Liu X, et al
    Arginine and lysine methylation of MRPS23 promotes breast cancer metastasis through regulating OXPHOS.
    Oncogene. 2021 Apr 29. pii: 10.1038/s41388-021-01785.
    >> Share

  18. STEBBING J, Zhang H, Xu Y, Lit LC, et al
    Correction to: KSR1 regulates BRCA1 degradation and inhibits breast cancer growth.
    Oncogene. 2021 Apr 22. pii: 10.1038/s41388-021-01759.
    >> Share

  19. TRAPHAGEN NA, Hosford SR, Jiang A, Marotti JD, et al
    High estrogen receptor alpha activation confers resistance to estrogen deprivation and is required for therapeutic response to estrogen in breast cancer.
    Oncogene. 2021 Apr 19. pii: 10.1038/s41388-021-01782.
    >> Share

  20. KIM ES, Nam SM, Song HK, Lee S, et al
    CCL8 mediates crosstalk between endothelial colony forming cells and triple-negative breast cancer cells through IL-8, aggravating invasion and tumorigenicity.
    Oncogene. 2021 Apr 8. pii: 10.1038/s41388-021-01758.
    >> Share

    March 2021
  21. LIANG Y, Song X, Li Y, Su P, et al
    Correction: circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer.
    Oncogene. 2021 Mar 25. pii: 10.1038/s41388-021-01750.
    >> Share

  22. WANG X, Feng M, Xiao T, Guo B, et al
    BCL9/BCL9L promotes tumorigenicity through immune-dependent and independent mechanisms in triple negative breast cancer.
    Oncogene. 2021 Mar 25. pii: 10.1038/s41388-021-01756.
    >> Share

  23. HUTCHINSON SA, Websdale A, Cioccoloni G, Roberg-Larsen H, et al
    Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer.
    Oncogene. 2021 Mar 19. pii: 10.1038/s41388-021-01720.
    >> Share

  24. WANG YH, Chan YT, Hung TH, Hung JT, et al
    Transmembrane and coiled-coil domain family 3 (TMCC3) regulates breast cancer stem cell and AKT activation.
    Oncogene. 2021 Mar 19. pii: 10.1038/s41388-021-01729.
    >> Share

  25. MARTINEZ-ORDONEZ A, Seoane S, Avila L, Eiro N, et al
    POU1F1 transcription factor induces metabolic reprogramming and breast cancer progression via LDHA regulation.
    Oncogene. 2021 Mar 13. pii: 10.1038/s41388-021-01740.
    >> Share

  26. CHEN T, Wang X, Li C, Zhang H, et al
    CircHIF1A regulated by FUS accelerates triple-negative breast cancer progression by modulating NFIB expression and translocation.
    Oncogene. 2021 Mar 13. pii: 10.1038/s41388-021-01739.
    >> Share

  27. KIM H, Son S, Ko Y, Shin I, et al
    CTGF regulates cell proliferation, migration, and glucose metabolism through activation of FAK signaling in triple-negative breast cancer.
    Oncogene. 2021 Mar 10. pii: 10.1038/s41388-021-01731.
    >> Share

  28. BERDIEL-ACER M, Maia A, Hristova Z, Borgoni S, et al
    Stromal NRG1 in luminal breast cancer defines pro-fibrotic and migratory cancer-associated fibroblasts.
    Oncogene. 2021 Mar 10. pii: 10.1038/s41388-021-01719.
    >> Share

  29. JALALIRAD M, Haddad TC, Salisbury JL, Radisky D, et al
    Aurora-A kinase oncogenic signaling mediates TGF-beta-induced triple-negative breast cancer plasticity and chemoresistance.
    Oncogene. 2021 Mar 5. pii: 10.1038/s41388-021-01711.
    >> Share

  30. REINSBOROUGH CW, Ipas H, Abell NS, Gouws EB, et al
    BCDIN3D RNA methyltransferase stimulates Aldolase C expression and glycolysis through let-7 microRNA in breast cancer cells.
    Oncogene. 2021 Mar 4. pii: 10.1038/s41388-021-01702.
    >> Share

  31. SIRKISOON SR, Carpenter RL, Rimkus T, Doheny D, et al
    Correction: TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment.
    Oncogene. 2021 Mar 2. pii: 10.1038/s41388-020-01620.
    >> Share

  32. GE LP, Jin X, Yang YS, Liu XY, et al
    Tektin4 loss promotes triple-negative breast cancer metastasis through HDAC6-mediated tubulin deacetylation and increases sensitivity to HDAC6 inhibitor.
    Oncogene. 2021 Mar 2. pii: 10.1038/s41388-021-01655.
    >> Share

  33. VARONE E, Decio A, Chernorudskiy A, Minoli L, et al
    The ER stress response mediator ERO1 triggers cancer metastasis by favoring the angiogenic switch in hypoxic conditions.
    Oncogene. 2021;40:1721-1736.
    >> Share

    February 2021
  34. WU R, Li K, Yuan M, Luo KQ, et al
    Nerve growth factor receptor increases the tumor growth and metastatic potential of triple-negative breast cancer cells.
    Oncogene. 2021 Feb 24. pii: 10.1038/s41388-021-01691.
    >> Share

  35. BUTTI R, Nimma R, Kundu G, Bulbule A, et al
    Tumor-derived osteopontin drives the resident fibroblast to myofibroblast differentiation through Twist1 to promote breast cancer progression.
    Oncogene. 2021 Feb 18. pii: 10.1038/s41388-021-01663.
    >> Share

  36. WANG G, Wang J, Chang A, Cheng D, et al
    Correction to: Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2.
    Oncogene. 2021 Feb 10. pii: 10.1038/s41388-021-01652.
    >> Share

  37. KUNG CP, Cottrell KA, Ryu S, Bramel ER, et al
    Correction to: Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer.
    Oncogene. 2021 Feb 9. pii: 10.1038/s41388-021-01669.
    >> Share

  38. PAN JK, Lin CH, Kuo YL, Ger LP, et al
    MiR-211 determines brain metastasis specificity through SOX11/NGN2 axis in triple-negative breast cancer.
    Oncogene. 2021 Feb 3. pii: 10.1038/s41388-021-01654.
    >> Share

  39. CHEN D, Parker TM, Bhat-Nakshatri P, Chu X, et al
    Nonlinear relationship between chromatin accessibility and estradiol-regulated gene expression.
    Oncogene. 2021;40:1332-1346.
    >> Share

  40. AL-AKHRASS H, Conway JRW, Poulsen ASA, Paatero I, et al
    A feed-forward loop between SorLA and HER3 determines heregulin response and neratinib resistance.
    Oncogene. 2021;40:1300-1317.
    >> Share

  41. GU G, Tian L, Herzog SK, Rechoum Y, et al
    Hormonal modulation of ESR1 mutant metastasis.
    Oncogene. 2021;40:997-1011.
    >> Share

    January 2021
  42. ABRIL YLN, Fernandez IR, Hong JY, Chiang YL, et al
    Pharmacological and genetic perturbation establish SIRT5 as a promising target in breast cancer.
    Oncogene. 2021 Jan 21. pii: 10.1038/s41388-020-01637.
    >> Share

  43. ZHU P, He F, Hou Y, Tu G, et al
    A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability.
    Oncogene. 2021 Jan 19. pii: 10.1038/s41388-020-01638.
    >> Share

  44. ZHANG H, Wong CCL, Wei H, Gilkes DM, et al
    Correction: HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs.
    Oncogene. 2021 Jan 15. pii: 10.1038/s41388-020-01618.
    >> Share

  45. VARESLIJA D, Ward E, Purcell SP, Cosgrove NS, et al
    Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype.
    Oncogene. 2021 Jan 8. pii: 10.1038/s41388-020-01606.
    >> Share

  46. PANTANO F, Croset M, Driouch K, Bednarz-Knoll N, et al
    Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions.
    Oncogene. 2021 Jan 8. pii: 10.1038/s41388-020-01603.
    >> Share

  47. YOUSEFI H, Vatanmakanian M, Mahdiannasser M, Mashouri L, et al
    Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance.
    Oncogene. 2021 Jan 8. pii: 10.1038/s41388-020-01588.
    >> Share

  48. TIEDE S, Kalathur RKR, Luond F, von Allmen L, et al
    Multi-color clonal tracking reveals intra-stage proliferative heterogeneity during mammary tumor progression.
    Oncogene. 2021;40:12-27.
    >> Share

    December 2020
  49. KONG D, Zhou H, Neelakantan D, Hughes CJ, et al
    VEGF-C mediates tumor growth and metastasis through promoting EMT-epithelial breast cancer cell crosstalk.
    Oncogene. 2020 Dec 9. pii: 10.1038/s41388-020-01539.
    >> Share

  50. HAN J, Qu H, Han M, Ding Y, et al
    MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer.
    Oncogene. 2020 Dec 3. pii: 10.1038/s41388-020-01574.
    >> Share

  51. SONG Y, Zeng S, Zheng G, Chen D, et al
    FOXO3a-driven miRNA signatures suppresses VEGF-A/NRP1 signaling and breast cancer metastasis.
    Oncogene. 2020 Dec 1. pii: 10.1038/s41388-020-01562.
    >> Share

    November 2020
  52. ATTALLA S, Taifour T, Bui T, Muller W, et al
    Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo.
    Oncogene. 2020 Nov 24. pii: 10.1038/s41388-020-01560.
    >> Share

  53. GUAN X, Deng H, Choi UL, Li Z, et al
    EZH2 overexpression dampens tumor-suppressive signals via an EGR1 silencer to drive breast tumorigenesis.
    Oncogene. 2020;39:7127-7141.
    >> Share

    October 2020
  54. ABDULLAH A, Akhand SS, Paez JSP, Brown W, et al
    Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer.
    Oncogene. 2020 Oct 30. pii: 10.1038/s41388-020-01530.
    >> Share

  55. KUNG CP, Cottrell KA, Ryu S, Bramel ER, et al
    Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer.
    Oncogene. 2020 Oct 27. pii: 10.1038/s41388-020-01515.
    >> Share

  56. ZHENG X, Lu S, He Z, Huang H, et al
    MCU-dependent negative sorting of miR-4488 to extracellular vesicles enhances angiogenesis and promotes breast cancer metastatic colonization.
    Oncogene. 2020 Oct 16. pii: 10.1038/s41388-020-01514.
    >> Share

  57. LI Y, Li L, Qin J, Wu J, et al
    OSR1 phosphorylates the Smad2/3 linker region and induces TGF-beta1 autocrine to promote EMT and metastasis in breast cancer.
    Oncogene. 2020 Oct 13. pii: 10.1038/s41388-020-01499.
    >> Share

  58. ZHANG L, Qin Y, Wu G, Wang J, et al
    PRRG4 promotes breast cancer metastasis through the recruitment of NEDD4 and downregulation of Robo1.
    Oncogene. 2020 Oct 9. pii: 10.1038/s41388-020-01494.
    >> Share

  59. CHEN H, Libring S, Ruddraraju KV, Miao J, et al
    SHP2 is a multifunctional therapeutic target in drug resistant metastatic breast cancer.
    Oncogene. 2020 Oct 8. pii: 10.1038/s41388-020-01488.
    >> Share

  60. WANG S, Somisetty VS, Bai B, Chernukhin I, et al
    The proapoptotic gene interferon regulatory factor-1 mediates the antiproliferative outcome of paired box 2 gene and tamoxifen.
    Oncogene. 2020;39:6300-6312.
    >> Share

    September 2020
  61. WANG G, Wang J, Chang A, Cheng D, et al
    Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2.
    Oncogene. 2020 Sep 28. pii: 10.1038/s41388-020-01481.
    >> Share

  62. ZHU J, Li X, Su P, Xue M, et al
    The ubiquitin ligase RNF181 stabilizes ERalpha and modulates breast cancer progression.
    Oncogene. 2020 Sep 24. pii: 10.1038/s41388-020-01464.
    >> Share

  63. LI LY, Chen XS, Wang KS, Guan YD, et al
    RSK2 protects human breast cancer cells under endoplasmic reticulum stress through activating AMPKalpha2-mediated autophagy.
    Oncogene. 2020 Sep 21. pii: 10.1038/s41388-020-01447.
    >> Share

  64. DOHENY D, Sirkisoon S, Carpenter RL, Aguayo NR, et al
    Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis.
    Oncogene. 2020 Sep 14. pii: 10.1038/s41388-020-01454.
    >> Share

    August 2020
  65. MURRAY AS, Hyland TE, Sala-Hamrick KE, Mackinder JR, et al
    The cell-surface anchored serine protease TMPRSS13 promotes breast cancer progression and resistance to chemotherapy.
    Oncogene. 2020 Aug 31. pii: 10.1038/s41388-020-01436.
    >> Share

  66. VERNIER M, McGuirk S, Dufour CR, Wan L, et al
    Inhibition of DNMT1 and ERRalpha crosstalk suppresses breast cancer via derepression of IRF4.
    Oncogene. 2020 Aug 27. pii: 10.1038/s41388-020-01438.
    >> Share

  67. WANG J, Wang G, Cheng D, Huang S, et al
    Her2 promotes early dissemination of breast cancer by suppressing the p38-MK2-Hsp27 pathway that is targetable by Wip1 inhibition.
    Oncogene. 2020 Aug 26. pii: 10.1038/s41388-020-01437.
    >> Share

  68. CHERVO MF, Cordo Russo RI, Petrillo E, Izzo F, et al
    Canonical ErbB-2 isoform and ErbB-2 variant c located in the nucleus drive triple negative breast cancer growth.
    Oncogene. 2020 Aug 25. pii: 10.1038/s41388-020-01430.
    >> Share

  69. LIU H, Gruber CW, Alewood PF, Moller A, et al
    The oxytocin receptor signalling system and breast cancer: a critical review.
    Oncogene. 2020 Aug 11. pii: 10.1038/s41388-020-01415.
    >> Share

  70. LIN B, Li Y, Wang T, Qiu Y, et al
    CRMP2 is a therapeutic target that suppresses the aggressiveness of breast cancer cells by stabilizing RECK.
    Oncogene. 2020 Aug 10. pii: 10.1038/s41388-020-01412.
    >> Share

  71. WANG M, Long K, Li E, Li L, et al
    DNA polymerase beta modulates cancer progression via enhancing CDH13 expression by promoter demethylation.
    Oncogene. 2020;39:5507-5519.
    >> Share

    July 2020
  72. YANG H, Geng YH, Wang P, Yang H, et al
    Extracellular ATP promotes breast cancer invasion and chemoresistance via SOX9 signaling.
    Oncogene. 2020 Jul 28. pii: 10.1038/s41388-020-01402.
    >> Share

  73. BUSCHHAUS JM, Humphries BA, Eckley SS, Robison TH, et al
    Targeting disseminated estrogen-receptor-positive breast cancer cells in bone marrow.
    Oncogene. 2020 Jul 16. pii: 10.1038/s41388-020-01391.
    >> Share

  74. CHAI TF, Manu KA, Casey PJ, Wang M, et al
    Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal.
    Oncogene. 2020;39:5373-5389.
    >> Share

    June 2020
  75. HRUSCHKA N, Kalisz M, Subijana M, Grana-Castro O, et al
    The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driver.
    Oncogene. 2020 Jun 25. pii: 10.1038/s41388-020-1376.
    >> Share

  76. SUN T, Wu Z, Wang X, Wang Y, et al
    LNC942 promoting METTL14-mediated m(6)A methylation in breast cancer cell proliferation and progression.
    Oncogene. 2020 Jun 23. pii: 10.1038/s41388-020-1338.
    >> Share

  77. JIANG K, Liu P, Xu H, Liang D, et al
    SASH1 suppresses triple-negative breast cancer cell invasion through YAP-ARHGAP42-actin axis.
    Oncogene. 2020 Jun 10. pii: 10.1038/s41388-020-1356.
    >> Share

  78. AN P, Chen F, Li Z, Ling Y, et al
    HDAC8 promotes the dissemination of breast cancer cells via AKT/GSK-3beta/Snail signals.
    Oncogene. 2020 Jun 4. pii: 10.1038/s41388-020-1337.
    >> Share

  79. AL-ZAHRANI KN, Abou-Hamad J, Cook DP, Pryce BR, et al
    Loss of the Ste20-like kinase induces a basal/stem-like phenotype in HER2-positive breast cancers.
    Oncogene. 2020;39:4592-4602.
    >> Share

  80. TABATABAEIAN H, Rao A, Ramos A, Chu T, et al
    The emerging roles of WBP2 oncogene in human cancers.
    Oncogene. 2020;39:4621-4635.
    >> Share

  81. PANCHOLI S, Ribas R, Simigdala N, Schuster E, et al
    Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities.
    Oncogene. 2020;39:4781-4797.
    >> Share

    May 2020
  82. SIMOES BM, Santiago-Gomez A, Chiodo C, Moreira T, et al
    Targeting STAT3 signaling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancer.
    Oncogene. 2020 May 30. pii: 10.1038/s41388-020-1335.
    >> Share

  83. MEYER-SCHALLER N, Tiede S, Ivanek R, Diepenbruck M, et al
    A dual role of Irf1 in maintaining epithelial identity but also enabling EMT and metastasis formation of breast cancer cells.
    Oncogene. 2020 May 14. pii: 10.1038/s41388-020-1326.
    >> Share

  84. JIANG M, Zhang W, Zhang R, Liu P, et al
    Cancer exosome-derived miR-9 and miR-181a promote the development of early-stage MDSCs via interfering with SOCS3 and PIAS3 respectively in breast cancer.
    Oncogene. 2020 May 12. pii: 10.1038/s41388-020-1322.
    >> Share

  85. SHMULEVICH R, Nissim TB, Wolf I, Merenbakh-Lamin K, et al
    Klotho rewires cellular metabolism of breast cancer cells through alteration of calcium shuttling and mitochondrial activity.
    Oncogene. 2020 May 12. pii: 10.1038/s41388-020-1313.
    >> Share

  86. YONEDA A, Minomi K, Tamura Y
    HSP47 promotes metastasis of breast cancer by interacting with myosin IIA via the unfolded protein response transducer IRE1alpha.
    Oncogene. 2020 May 4. pii: 10.1038/s41388-020-1311.
    >> Share

    April 2020
  87. SUNDQVIST A, Vasilaki E, Voytyuk O, Bai Y, et al
    TGFbeta and EGF signaling orchestrates the AP-1- and p63 transcriptional regulation of breast cancer invasiveness.
    Oncogene. 2020 Apr 29. pii: 10.1038/s41388-020-1299.
    >> Share

  88. CASSANDRI M, Butera A, Amelio I, Lena AM, et al
    ZNF750 represses breast cancer invasion via epigenetic control of prometastatic genes.
    Oncogene. 2020 Apr 20. pii: 10.1038/s41388-020-1277.
    >> Share

  89. KLUZ PN, Kolb R, Xie Q, Borcherding N, et al
    Cancer cell-intrinsic function of CD177 in attenuating beta-catenin signaling.
    Oncogene. 2020;39:2877-2889.
    >> Share

  90. JEANNOT E, Darrigues L, Michel M, Stern MH, et al
    A single droplet digital PCR for ESR1 activating mutations detection in plasma.
    Oncogene. 2020;39:2987-2995.
    >> Share

  91. FRANCART ME, Vanwynsberghe AM, Lambert J, Bourcy M, et al
    Vimentin prevents a miR-dependent negative regulation of tissue factor mRNA during epithelial-mesenchymal transitions and facilitates early metastasis.
    Oncogene. 2020;39:3680-3692.
    >> Share

    March 2020
  92. HE J, McLaughlin RP, van der Beek L, Canisius S, et al
    Integrative analysis of genomic amplification-dependent expression and loss-of-function screen identifies ASAP1 as a driver gene in triple-negative breast cancer progression.
    Oncogene. 2020 Mar 31. pii: 10.1038/s41388-020-1279.
    >> Share

  93. ARNOLD JM, Gu F, Ambati CR, Rasaily U, et al
    Correction: UDP-glucose 6-dehydrogenase regulates hyaluronic acid production and promotes breast cancer progression.
    Oncogene. 2020 Mar 25. pii: 10.1038/s41388-020-1252.
    >> Share

  94. HSU BE, Roy J, Mouhanna J, Rayes RF, et al
    C3a elicits unique migratory responses in immature low-density neutrophils.
    Oncogene. 2020;39:2612-2623.
    >> Share

  95. BRUMMER G, Fang W, Smart C, Zinda B, et al
    CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments.
    Oncogene. 2020;39:2275-2289.
    >> Share

    February 2020
  96. YOE J, Kim D, Kim S, Lee Y, et al
    Capicua restricts cancer stem cell-like properties in breast cancer cells.
    Oncogene. 2020 Feb 27. pii: 10.1038/s41388-020-1230.
    >> Share

  97. BROWN TP, Bhattacharjee P, Ramachandran S, Sivaprakasam S, et al
    The lactate receptor GPR81 promotes breast cancer growth via a paracrine mechanism involving antigen-presenting cells in the tumor microenvironment.
    Oncogene. 2020 Feb 19. pii: 10.1038/s41388-020-1216.
    >> Share

  98. BESSOU M, Lopez J, Gadet R, Deygas M, et al
    The apoptosis inhibitor Bcl-xL controls breast cancer cell migration through mitochondria-dependent reactive oxygen species production.
    Oncogene. 2020 Feb 17. pii: 10.1038/s41388-020-1212.
    >> Share

  99. GONG C, Tsoi H, Mok KC, Cheung J, et al
    Phosphorylation independent eIF4E translational reprogramming of selective mRNAs determines tamoxifen resistance in breast cancer.
    Oncogene. 2020 Feb 17. pii: 10.1038/s41388-020-1210.
    >> Share

  100. FARHAT D, Ghayad SE, Icard P, Le Romancer M, et al
    Lipoic acid-induced oxidative stress abrogates IGF-1R maturation by inhibiting the CREB/furin axis in breast cancer cell lines.
    Oncogene. 2020 Feb 14. pii: 10.1038/s41388-020-1211.
    >> Share

  101. KENNEDY SP, O'Neill M, Cunningham D, Morris PG, et al
    Preclinical evaluation of a novel triple-acting PIM/PI3K/mTOR inhibitor, IBL-302, in breast cancer.
    Oncogene. 2020 Feb 10. pii: 10.1038/s41388-020-1202.
    >> Share

  102. TARULLO SE, Hill RC, Hansen KC, Behbod F, et al
    Postpartum breast cancer progression is driven by semaphorin 7a-mediated invasion and survival.
    Oncogene. 2020 Feb 4. pii: 10.1038/s41388-020-1192.
    >> Share

  103. LEFORT S, Tan S, Balani S, Rafn B, et al
    Initiation of human mammary cell tumorigenesis by mutant KRAS requires YAP inactivation.
    Oncogene. 2020;39:1957-1968.
    >> Share

    January 2020
  104. RAN R, Harrison H, Syamimi Ariffin N, Ayub R, et al
    A role for CBFbeta in maintaining the metastatic phenotype of breast cancer cells.
    Oncogene. 2020 Jan 31. pii: 10.1038/s41388-020-1170.
    >> Share

  105. ZHANG J, Lin X, Wu L, Huang JJ, et al
    Aurora B induces epithelial-mesenchymal transition by stabilizing Snail1 to promote basal-like breast cancer metastasis.
    Oncogene. 2020 Jan 29. pii: 10.1038/s41388-020-1165.
    >> Share

  106. WU X, Zhang X, Yu L, Zhang C, et al
    Zinc finger protein 367 promotes metastasis by inhibiting the Hippo pathway in breast cancer.
    Oncogene. 2020 Jan 27. pii: 10.1038/s41388-020-1166.
    >> Share

  107. MCGINN O, Ward AV, Fettig LM, Riley D, et al
    Cytokeratin 5 alters beta-catenin dynamics in breast cancer cells.
    Oncogene. 2020 Jan 27. pii: 10.1038/s41388-020-1164.
    >> Share

  108. WU HJ, Hao M, Yeo SK, Guan JL, et al
    FAK signaling in cancer-associated fibroblasts promotes breast cancer cell migration and metastasis by exosomal miRNAs-mediated intercellular communication.
    Oncogene. 2020 Jan 27. pii: 10.1038/s41388-020-1162.
    >> Share

  109. DIAS MM, Adamoski D, Dos Reis LM, Ascencao CFR, et al
    GLS2 is protumorigenic in breast cancers.
    Oncogene. 2020;39:690-702.
    >> Share

  110. SUNG JS, Kang CW, Kang S, Jang Y, et al
    ITGB4-mediated metabolic reprogramming of cancer-associated fibroblasts.
    Oncogene. 2020;39:664-676.
    >> Share

  111. SAVA GP, Fan H, Fisher RA, Lusvarghi S, et al
    ABC-transporter upregulation mediates resistance to the CDK7 inhibitors THZ1 and ICEC0942.
    Oncogene. 2020;39:651-663.
    >> Share

    December 2019
  112. FANG R, Xu F, Shi H, Wu Y, et al
    LAMTOR5 raises abnormal initiation of O-glycosylation in breast cancer metastasis via modulating GALNT1 activity.
    Oncogene. 2019 Dec 13. pii: 10.1038/s41388-019-1146.
    >> Share

  113. LI K, Zhang J, Tian Y, He Y, et al
    The Wnt/beta-catenin/VASP positive feedback loop drives cell proliferation and migration in breast cancer.
    Oncogene. 2019 Dec 12. pii: 10.1038/s41388-019-1145.
    >> Share

  114. NEELI PK, Gollavilli PN, Mallappa S, Hari SG, et al
    A novel metadherinDelta7 splice variant enhances triple negative breast cancer aggressiveness by modulating mitochondrial function via NFkB-SIRT3 axis.
    Oncogene. 2019 Dec 5. pii: 10.1038/s41388-019-1126.
    >> Share

  115. QIAN T, Liu C, Ding Y, Guo C, et al
    PINCH-1 interacts with myoferlin to promote breast cancer progression and metastasis.
    Oncogene. 2019 Dec 4. pii: 10.1038/s41388-019-1135.
    >> Share

    November 2019
  116. AMES S, Andring JT, McKenna R, Becker HM, et al
    CAIX forms a transport metabolon with monocarboxylate transporters in human breast cancer cells.
    Oncogene. 2019 Nov 13. pii: 10.1038/s41388-019-1098.
    >> Share

  117. BONETTI P, Climent M, Panebianco F, Tordonato C, et al
    Correction: Dual role for miR-34a in the control of early progenitor proliferation and commitment in the mammary gland and in breast cancer.
    Oncogene. 2019 Nov 8. pii: 10.1038/s41388-019-1094.
    >> Share

  118. CHENG R, Billet S, Liu C, Haldar S, et al
    Periodontal inflammation recruits distant metastatic breast cancer cells by increasing myeloid-derived suppressor cells.
    Oncogene. 2019 Nov 4. pii: 10.1038/s41388-019-1084.
    >> Share

    October 2019
  119. CLEMENTS ME, Johnson RW
    PREX1 drives spontaneous bone dissemination of ER+ breast cancer cells.
    Oncogene. 2019 Oct 21. pii: 10.1038/s41388-019-1064.
    >> Share

  120. FRANKE CM, Gu VW, Grimm BG, Cassady VC, et al
    TFAP2C regulates carbonic anhydrase XII in human breast cancer.
    Oncogene. 2019 Oct 21. pii: 10.1038/s41388-019-1062.
    >> Share

  121. YOUSEFI H, Maheronnaghsh M, Molaei F, Mashouri L, et al
    Long noncoding RNAs and exosomal lncRNAs: classification, and mechanisms in breast cancer metastasis and drug resistance.
    Oncogene. 2019 Oct 10. pii: 10.1038/s41388-019-1040.
    >> Share

  122. WILLIAMS CB, Phelps-Polirer K, Dingle IP, Williams CJ, et al
    HUNK phosphorylates EGFR to regulate breast cancer metastasis.
    Oncogene. 2019 Oct 9. pii: 10.1038/s41388-019-1046.
    >> Share

    September 2019
  123. CHANG YW, Tseng CF, Wang MY, Chang WC, et al
    Correction: Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer.
    Oncogene. 2019 Sep 19. pii: 10.1038/s41388-019-0981.
    >> Share

  124. YANG T, Ren C, Qiao P, Han X, et al
    Correction: PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer.
    Oncogene. 2019 Sep 11. pii: 10.1038/s41388-019-0982.
    >> Share

    August 2019
  125. LU X, Liu R, Wang M, Kumar AK, et al
    MicroRNA-140 impedes DNA repair by targeting FEN1 and enhances chemotherapeutic response in breast cancer.
    Oncogene. 2019 Aug 30. pii: 10.1038/s41388-019-0986.
    >> Share

  126. SIRKISOON SR, Carpenter RL, Rimkus T, Doheny D, et al
    TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment.
    Oncogene. 2019 Aug 28. pii: 10.1038/s41388-019-0959.
    >> Share

  127. CEBRIA-COSTA JP, Pascual-Reguant L, Gonzalez-Perez A, Serra-Bardenys G, et al
    LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells.
    Oncogene. 2019 Aug 28. pii: 10.1038/s41388-019-0969.
    >> Share

  128. YAO N, Fu Y, Chen L, Liu Z, et al
    Long non-coding RNA NONHSAT101069 promotes epirubicin resistance, migration, and invasion of breast cancer cells through NONHSAT101069/miR-129-5p/Twist1 axis.
    Oncogene. 2019 Aug 23. pii: 10.1038/s41388-019-0904.
    >> Share

  129. HU X, Xiang D, Xie Y, Tao L, et al
    LSD1 suppresses invasion, migration and metastasis of luminal breast cancer cells via activation of GATA3 and repression of TRIM37 expression.
    Oncogene. 2019 Aug 13. pii: 10.1038/s41388-019-0923.
    >> Share

  130. PIQUE L, Martinez de Paz A, Pineyro D, Martinez-Cardus A, et al
    Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancer.
    Oncogene. 2019 Aug 13. pii: 10.1038/s41388-019-0936.
    >> Share

  131. LIANG Y, Song X, Li Y, Su P, et al
    circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer.
    Oncogene. 2019 Aug 12. pii: 10.1038/s41388-019-0926.
    >> Share

  132. JALLOW F, O'Leary KA, Rugowski DE, Guerrero JF, et al
    Dynamic interactions between the extracellular matrix and estrogen activity in progression of ER+ breast cancer.
    Oncogene. 2019 Aug 12. pii: 10.1038/s41388-019-0941.
    >> Share

  133. CASLINI C, Hong S, Ban YJ, Chen XS, et al
    HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells.
    Oncogene. 2019 Aug 2. pii: 10.1038/s41388-019-0897.
    >> Share

    July 2019
  134. CORDERO A, Kanojia D, Miska J, Panek WK, et al
    FABP7 is a key metabolic regulator in HER2+ breast cancer brain metastasis.
    Oncogene. 2019 Jul 19. pii: 10.1038/s41388-019-0893.
    >> Share

  135. ARNOLD JM, Gu F, Ambati CR, Rasaily U, et al
    UDP-glucose 6-dehydrogenase regulates hyaluronic acid production and promotes breast cancer progression.
    Oncogene. 2019 Jul 15. pii: 10.1038/s41388-019-0885.
    >> Share

  136. QIAN JY, Gao J, Sun X, Cao MD, et al
    KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner.
    Oncogene. 2019 Jul 8. pii: 10.1038/s41388-019-0861.
    >> Share

    June 2019
  137. CRAWFORD NT, McIntyre AJ, McCormick A, D'Costa ZC, et al
    TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells.
    Oncogene. 2019 Jun 28. pii: 10.1038/s41388-019-0853.
    >> Share

  138. ZHU Y, Xie M, Meng Z, Leung LK, et al
    Knockdown of TM9SF4 boosts ER stress to trigger cell death of chemoresistant breast cancer cells.
    Oncogene. 2019 Jun 27. pii: 10.1038/s41388-019-0846.
    >> Share

  139. LEE E, Ouzounova M, Piranlioglu R, Ma MT, et al
    Correction: The pleiotropic effects of TNFalpha in breast cancer subtypes is regulated by TNFAIP3/A20.
    Oncogene. 2019 Jun 13. pii: 10.1038/s41388-019-0838.
    >> Share

    May 2019
  140. HERNANDEZ-PEREZ S, Cabrera E, Salido E, Lim M, et al
    Correction: DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer.
    Oncogene. 2019 May 8. pii: 10.1038/s41388-019-0753.
    >> Share

  141. SORIA-VALLES C, Gutierrez-Fernandez A, Guiu M, Mari B, et al
    Correction: The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21.
    Oncogene. 2019 May 3. pii: 10.1038/s41388-019-0825.
    >> Share

  142. GUNARATNA RT, Santos A, Luo L, Nagi C, et al
    Dynamic role of the codon 72 p53 single-nucleotide polymorphism in mammary tumorigenesis in a humanized mouse model.
    Oncogene. 2019;38:3535-3550.
    >> Share

  143. TEW BY, Legendre C, Gooden GC, Johnson KN, et al
    Isolation and characterization of patient-derived CNS metastasis-associated stromal cell lines.
    Oncogene. 2019;38:4002-4014.
    >> Share

  144. DAS S, Nair RS, Mishra R, Sondarva G, et al
    Mixed lineage kinase 3 promotes breast tumorigenesis via phosphorylation and activation of p21-activated kinase 1.
    Oncogene. 2019;38:3569-3584.
    >> Share

  145. WILLIAMS KC, Cepeda MA, Javed S, Searle K, et al
    Invadopodia are chemosensing protrusions that guide cancer cell extravasation to promote brain tropism in metastasis.
    Oncogene. 2019;38:3598-3615.
    >> Share

    April 2019
  146. YANG RM, Nanayakkara D, Kalimutho M, Mitra P, et al
    MYB regulates the DNA damage response and components of the homology-directed repair pathway in human estrogen receptor-positive breast cancer cells.
    Oncogene. 2019 Apr 10. pii: 10.1038/s41388-019-0789.
    >> Share

  147. TAN BS, Yang MC, Singh S, Chou YC, et al
    LncRNA NORAD is repressed by the YAP pathway and suppresses lung and breast cancer metastasis by sequestering S100P.
    Oncogene. 2019 Apr 9. pii: 10.1038/s41388-019-0812.
    >> Share

  148. HE M, Jin Q, Chen C, Liu Y, et al
    The miR-186-3p/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells.
    Oncogene. 2019 Apr 9. pii: 10.1038/s41388-019-0817.
    >> Share

  149. YOSHINO Y, Qi H, Kanazawa R, Sugamata M, et al
    RACK1 regulates centriole duplication by controlling localization of BRCA1 to the centrosome in mammary tissue-derived cells.
    Oncogene. 2019;38:3077-3092.
    >> Share

  150. GOMES AM, Carron EC, Mills KL, Dow AM, et al
    Stromal Gas6 promotes the progression of premalignant mammary cells.
    Oncogene. 2019;38:2437-2450.
    >> Share

    March 2019
  151. KARADEDOU CT, Gomes AR, Chen J, Petkovic M, et al
    Correction: FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer.
    Oncogene. 2019 Mar 13. pii: 10.1038/s41388-019-0770.
    >> Share

  152. GOODING AJ, Zhang B, Gunawardane L, Beard A, et al
    The lncRNA BORG facilitates the survival and chemoresistance of triple-negative breast cancers.
    Oncogene. 2019;38:2020-2041.
    >> Share

  153. MARQUES M, Jangal M, Wang LC, Kazanets A, et al
    Oncogenic activity of poly (ADP-ribose) glycohydrolase.
    Oncogene. 2019;38:2177-2191.
    >> Share

  154. FEDOROVA O, Petukhov A, Daks A, Shuvalov O, et al
    Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis.
    Oncogene. 2019;38:2108-2122.
    >> Share

    February 2019
  155. SUN Y, Ding Y, Guo C, Liu C, et al
    alpha-Parvin promotes breast cancer progression and metastasis through interaction with G3BP2 and regulation of TWIST1 signaling.
    Oncogene. 2019 Feb 25. pii: 10.1038/s41388-019-0762.
    >> Share

  156. CONTRERAS-ZARATE MJ, Day NL, Ormond DR, Borges VF, et al
    Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases.
    Oncogene. 2019 Feb 22. pii: 10.1038/s41388-019-0756.
    >> Share

  157. BLOCK I, Muller C, Sdogati D, Pedersen H, et al
    CFP suppresses breast cancer cell growth by TES-mediated upregulation of the transcription factor DDIT3.
    Oncogene. 2019 Feb 12. pii: 10.1038/s41388-019-0739.
    >> Share

  158. KANG MH, Jeong KJ, Kim WY, Lee HJ, et al
    Correction: Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer.
    Oncogene. 2019 Feb 4. pii: 10.1038/s41388-019-0721.
    >> Share

  159. HUANG X, Wang XN, Yuan XD, Wu WY, et al
    XIAP facilitates breast and colon carcinoma growth via promotion of p62 depletion through ubiquitination-dependent proteasomal degradation.
    Oncogene. 2019;38:1448-1460.
    >> Share

  160. INESS AN, Felthousen J, Ananthapadmanabhan V, Sesay F, et al
    The cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-Myb.
    Oncogene. 2019;38:1080-1092.
    >> Share

    January 2019
  161. CASTAGNOLI L, Cancila V, Cordoba-Romero SL, Faraci S, et al
    WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer.
    Oncogene. 2019 Jan 31. pii: 10.1038/s41388-019-0700.
    >> Share

  162. ZHAO Y, Qiao S, Hou X, Tian H, et al
    Bioengineered tumor microenvironments with naked mole rats high-molecular-weight hyaluronan induces apoptosis in breast cancer cells.
    Oncogene. 2019 Jan 30. pii: 10.1038/s41388-019-0719.
    >> Share

  163. WOOSLEY AN, Dalton AC, Hussey GS, Howley BV, et al
    TGFbeta promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis.
    Oncogene. 2019 Jan 28. pii: 10.1038/s41388-019-0703.
    >> Share

  164. CHOUCAIR A, Pham TH, Omarjee S, Jacquemetton J, et al
    The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer.
    Oncogene. 2019 Jan 28. pii: 10.1038/s41388-019-0694.
    >> Share

  165. ZHOU XL, Zhu CY, Wu ZG, Guo X, et al
    The oncoprotein HBXIP competitively binds KEAP1 to activate NRF2 and enhance breast cancer cell growth and metastasis.
    Oncogene. 2019 Jan 28. pii: 10.1038/s41388-019-0698.
    >> Share

  166. KOHLER M, Ehrenfeld S, Halbach S, Lauinger M, et al
    B-Raf deficiency impairs tumor initiation and progression in a murine breast cancer model.
    Oncogene. 2019 Jan 18. pii: 10.1038/s41388-018-0663.
    >> Share

  167. KIM I, Shin SH, Lee JE, Park JW, et al
    Oxygen sensor FIH inhibits HACE1-dependent ubiquitination of Rac1 to enhance metastatic potential in breast cancer cells.
    Oncogene. 2019 Jan 18. pii: 10.1038/s41388-019-0676.
    >> Share

  168. PANAGOPOULOU M, Karaglani M, Balgkouranidou I, Biziota E, et al
    Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers.
    Oncogene. 2019 Jan 14. pii: 10.1038/s41388-018-0660.
    >> Share

  169. MANN J, Githaka JM, Buckland TW, Yang N, et al
    Non-canonical BAD activity regulates breast cancer cell and tumor growth via 14-3-3 binding and mitochondrial metabolism.
    Oncogene. 2019 Jan 11. pii: 10.1038/s41388-018-0673.
    >> Share

  170. DOMENICI G, Aurrekoetxea-Rodriguez I, Simoes BM, Rabano M, et al
    A Sox2-Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells.
    Oncogene. 2019 Jan 8. pii: 10.1038/s41388-018-0656.
    >> Share

    December 2018
  171. MARUSIAK AA, Prelowska MK, Mehlich D, Lazniewski M, et al
    Upregulation of MLK4 promotes migratory and invasive potential of breast cancer cells.
    Oncogene. 2018 Dec 14. pii: 10.1038/s41388-018-0618.
    >> Share

  172. LAN Q, Peyvandi S, Duffey N, Huang YT, et al
    Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer.
    Oncogene. 2018 Dec 13. pii: 10.1038/s41388-018-0624.
    >> Share

  173. PARONI G, Bolis M, Zanetti A, Ubezio P, et al
    HER2-positive breast-cancer cell lines are sensitive to KDM5 inhibition: definition of a gene-expression model for the selection of sensitive cases.
    Oncogene. 2018 Dec 11. pii: 10.1038/s41388-018-0620.
    >> Share

  174. MA A, Tang M, Zhang L, Wang B, et al
    USP1 inhibition destabilizes KPNA2 and suppresses breast cancer metastasis.
    Oncogene. 2018 Dec 7. pii: 10.1038/s41388-018-0590.
    >> Share

  175. GIANNI M, Terao M, Kurosaki M, Paroni G, et al
    S100A3 a partner protein regulating the stability/activity of RARalpha and PML-RARalpha in cellular models of breast/lung cancer and acute myeloid leukemia.
    Oncogene. 2018 Dec 7. pii: 10.1038/s41388-018-0599.
    >> Share

  176. KOLB R, Kluz P, Tan ZW, Borcherding N, et al
    Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4.
    Oncogene. 2018 Dec 5. pii: 10.1038/s41388-018-0592.
    >> Share

    November 2018
  177. VARGAS G, Bouchet M, Bouazza L, Reboul P, et al
    ERRalpha promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors.
    Oncogene. 2018 Nov 26. pii: 10.1038/s41388-018-0579.
    >> Share

  178. ZHAO H, Martin E, Matalkah F, Shah N, et al
    Conditional knockout of SHP2 in ErbB2 transgenic mice or inhibition in HER2-amplified breast cancer cell lines blocks oncogene expression and tumorigenesis.
    Oncogene. 2018 Nov 22. pii: 10.1038/s41388-018-0574.
    >> Share

  179. TORRES-ADORNO AM, Vitrac H, Qi Y, Tan L, et al
    Eicosapentaenoic acid in combination with EPHA2 inhibition shows efficacy in preclinical models of triple-negative breast cancer by disrupting cellular cholesterol efflux.
    Oncogene. 2018 Nov 20. pii: 10.1038/s41388-018-0569.
    >> Share

  180. AN J, Du Y, Fan X, Wang Y, et al
    EGFL6 promotes breast cancer by simultaneously enhancing cancer cell metastasis and stimulating tumor angiogenesis.
    Oncogene. 2018 Nov 19. pii: 10.1038/s41388-018-0565.
    >> Share

  181. KUMAR S, Srivastav RK, Wilkes DW, Ross T, et al
    Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer.
    Oncogene. 2018 Nov 15. pii: 10.1038/s41388-018-0562.
    >> Share

  182. ZHAO Z, Hao D, Wang L, Li J, et al
    CtBP promotes metastasis of breast cancer through repressing cholesterol and activating TGF-beta signaling.
    Oncogene. 2018 Nov 15. pii: 10.1038/s41388-018-0570.
    >> Share

    September 2018
  183. BALAMURUGAN K, Mendoza-Villanueva D, Sharan S, Summers GH, et al
    C/EBPdelta links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes.
    Oncogene. 2018 Sep 27. pii: 10.1038/s41388-018-0516.
    >> Share

  184. ZHU J, Zhao C, Kharman-Biz A, Zhuang T, et al
    Correction: The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor alpha and modulates estrogen-stimulated breast cancer cell proliferation.
    Oncogene. 2018 Sep 27. pii: 10.1038/s41388-018-0502.
    >> Share

  185. ZHANG DD, Li Y, Xu Y, Kim J, et al
    Phosphodiesterase 7B/microRNA-200c relationship regulates triple-negative breast cancer cell growth.
    Oncogene. 2018 Sep 12. pii: 10.1038/s41388-018-0499.
    >> Share

  186. TRABOULSI T, El Ezzy M, Dumeaux V, Audemard E, et al
    Role of SUMOylation in differential ERalpha transcriptional repression by tamoxifen and fulvestrant in breast cancer cells.
    Oncogene. 2018 Sep 6. pii: 10.1038/s41388-018-0468.
    >> Share

  187. LIU Y, Long YH, Wang SQ, Zhang YY, et al
    JMJD6 regulates histone H2A.X phosphorylation and promotes autophagy in triple-negative breast cancer cells via a novel tyrosine kinase activity.
    Oncogene. 2018 Sep 5. pii: 10.1038/s41388-018-0466.
    >> Share

  188. GOTO H, Shimono Y, Funakoshi Y, Imamura Y, et al
    Adipose-derived stem cells enhance human breast cancer growth and cancer stem cell-like properties through adipsin.
    Oncogene. 2018 Sep 3. pii: 10.1038/s41388-018-0477.
    >> Share

  189. LI Y, Zhang H, Zhao Y, Wang C, et al
    A mandatory role of nuclear PAK4-LIFR axis in breast-to-bone metastasis of ERalpha-positive breast cancer cells.
    Oncogene. 2018 Sep 3. pii: 10.1038/s41388-018-0456.
    >> Share

    August 2018
  190. GUNTUKU L, Gangasani JK, Thummuri D, Borkar RM, et al
    IITZ-01, a novel potent lysosomotropic autophagy inhibitor, has single-agent antitumor efficacy in triple-negative breast cancer in vitro and in vivo.
    Oncogene. 2018 Aug 30. pii: 10.1038/s41388-018-0446.
    >> Share

  191. LEE E, Ouzounova M, Piranlioglu R, Ma MT, et al
    The pleiotropic effects of TNFalpha in breast cancer subtypes is regulated by TNFAIP3/A20.
    Oncogene. 2018 Aug 30. pii: 10.1038/s41388-018-0472.
    >> Share

  192. SARWAR M, Syed Khaja AS, Aleskandarany M, Karlsson R, et al
    The role of PIP5K1alpha/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1alpha inhibitor.
    Oncogene. 2018 Aug 13. pii: 10.1038/s41388-018-0438.
    >> Share

  193. BONETTI P, Climent M, Panebianco F, Tordonato C, et al
    Dual role for miR-34a in the control of early progenitor proliferation and commitment in the mammary gland and in breast cancer.
    Oncogene. 2018 Aug 9. pii: 10.1038/s41388-018-0445.
    >> Share

  194. LORENZO-MARTIN LF, Citterio C, Menacho-Marquez M, Conde J, et al
    Vav proteins maintain epithelial traits in breast cancer cells using miR-200c-dependent and independent mechanisms.
    Oncogene. 2018 Aug 7. pii: 10.1038/s41388-018-0433.
    >> Share

    July 2018
  195. CASTAGNINO A, Castro-Castro A, Irondelle M, Guichard A, et al
    Coronin 1C promotes triple-negative breast cancer invasiveness through regulation of MT1-MMP traffic and invadopodia function.
    Oncogene. 2018 Jul 31. pii: 10.1038/s41388-018-0422.
    >> Share

  196. HUANG X, Xie X, Liu P, Yang L, et al
    Adam12 and lnc015192 act as ceRNAs in breast cancer by regulating miR-34a.
    Oncogene. 2018 Jul 24. pii: 10.1038/s41388-018-0410.
    >> Share

  197. ZHANG B, Lyu J, Liu Y, Wu C, et al
    BRCA1 deficiency sensitizes breast cancer cells to bromodomain and extra-terminal domain (BET) inhibition.
    Oncogene. 2018 Jul 24. pii: 10.1038/s41388-018-0408.
    >> Share

  198. SHI L, Tang X, Qian M, Liu Z, et al
    A SIRT1-centered circuitry regulates breast cancer stemness and metastasis.
    Oncogene. 2018 Jul 23. pii: 10.1038/s41388-018-0370.
    >> Share

  199. LUO L, Tang H, Ling L, Li N, et al
    LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer.
    Oncogene. 2018 Jul 12. pii: 10.1038/s41388-018-0396.
    >> Share

  200. YANG T, Ren C, Qiao P, Han X, et al
    PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer.
    Oncogene. 2018 Jul 9. pii: 10.1038/s41388-018-0386.
    >> Share

  201. GUO X, Zhang Y, Mayakonda A, Madan V, et al
    ARID1A and CEBPalpha cooperatively inhibit UCA1 transcription in breast cancer.
    Oncogene. 2018 Jul 6. pii: 10.1038/s41388-018-0371.
    >> Share

  202. LI A, Chen P, Leng Y, Kang J, et al
    Histone deacetylase 6 regulates the immunosuppressive properties of cancer-associated fibroblasts in breast cancer through the STAT3-COX2-dependent pathway.
    Oncogene. 2018 Jul 6. pii: 10.1038/s41388-018-0379.
    >> Share

  203. DU WW, Yang W, Li X, Awan FM, et al
    A circular RNA circ-DNMT1 enhances breast cancer progression by activating autophagy.
    Oncogene. 2018 Jul 4. pii: 10.1038/s41388-018-0369.
    >> Share

  204. CUI YH, Kim H, Lee M, Yi JM, et al
    FBXL14 abolishes breast cancer progression by targeting CDCP1 for proteasomal degradation.
    Oncogene. 2018 Jul 4. pii: 10.1038/s41388-018-0372.
    >> Share

  205. GOLFMANN K, Meder L, Koker M, Volz C, et al
    Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer.
    Oncogene. 2018 Jul 3. pii: 10.1038/s41388-018-0380.
    >> Share

    June 2018
  206. BROUGH R, Gulati A, Haider S, Kumar R, et al
    Identification of highly penetrant Rb-related synthetic lethal interactions in triple negative breast cancer.
    Oncogene. 2018 Jun 18. pii: 10.1038/s41388-018-0368.
    >> Share

  207. LEE S, Axelsen TV, Jessen N, Pedersen SF, et al
    Na(+),HCO3(-)-cotransporter NBCn1 (Slc4a7) accelerates ErbB2-induced breast cancer development and tumor growth in mice.
    Oncogene. 2018 Jun 15. pii: 10.1038/s41388-018-0353.
    >> Share

    May 2018
  208. LU L, Dong J, Wang L, Xia Q, et al
    Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide.
    Oncogene. 2018 May 31. pii: 10.1038/s41388-018-0340.
    >> Share

  209. SIRINIAN C, Papanastasiou AD, Schizas M, Spella M, et al
    RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-kappaB activation and EGFR signaling.
    Oncogene. 2018 May 29. pii: 10.1038/s41388-018-0324.
    >> Share

  210. TANG J, Li Y, Sang Y, Yu B, et al
    LncRNA PVT1 regulates triple-negative breast cancer through KLF5/beta-catenin signaling.
    Oncogene. 2018 May 15. pii: 10.1038/s41388-018-0310.
    >> Share

  211. GALA K, Li Q, Sinha A, Razavi P, et al
    KMT2C mediates the estrogen dependence of breast cancer through regulation of ERalpha enhancer function.
    Oncogene. 2018 May 14. pii: 10.1038/s41388-018-0273.
    >> Share

  212. WANG PS, Chou CH, Lin CH, Yao YC, et al
    A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer.
    Oncogene. 2018 May 14. pii: 10.1038/s41388-018-0293.
    >> Share

  213. ROGERS S, McCloy RA, Parker BL, Gallego-Ortega D, et al
    MASTL overexpression promotes chromosome instability and metastasis in breast cancer.
    Oncogene. 2018 May 10. pii: 10.1038/s41388-018-0295.
    >> Share

  214. PAREKH A, Das S, Parida S, Das CK, et al
    Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo.
    Oncogene. 2018 May 10. pii: 10.1038/s41388-018-0272.
    >> Share

  215. BAKER A, Wyatt D, Bocchetta M, Li J, et al
    Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival.
    Oncogene. 2018 May 10. pii: 10.1038/s41388-018-0251.
    >> Share

  216. AHIRWAR DK, Nasser MW, Ouseph MM, Elbaz M, et al
    Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation.
    Oncogene. 2018 May 3. pii: 10.1038/s41388-018-0263.
    >> Share

  217. CHEN A, Sceneay J, Godde N, Kinwel T, et al
    Intermittent hypoxia induces a metastatic phenotype in breast cancer.
    Oncogene. 2018 May 1. pii: 10.1038/s41388-018-0259.
    >> Share

  218. PAVAN S, Meyer-Schaller N, Diepenbruck M, Kalathur RKR, et al
    A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.
    Oncogene. 2018 May 1. pii: 10.1038/s41388-018-0270.
    >> Share

    April 2018
  219. CHANG JW, Kuo WH, Lin CM, Chen WL, et al
    Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7-CYFIP1-mediated signaling pathway.
    Oncogene. 2018 Apr 30. pii: 10.1038/s41388-018-0253.
    >> Share

  220. TOOSI BM, El Zawily A, Truitt L, Shannon M, et al
    EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours.
    Oncogene. 2018 Apr 27. pii: 10.1038/s41388-018-0228.
    >> Share

  221. BLANCHETTE-FARRA N, Kita D, Konstorum A, Tesfay L, et al
    Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer.
    Oncogene. 2018 Apr 26. pii: 10.1038/s41388-018-0243.
    >> Share

  222. SUN L, Xu X, Chen Y, Zhou Y, et al
    Rab34 regulates adhesion, migration, and invasion of breast cancer cells.
    Oncogene. 2018 Apr 6. pii: 10.1038/s41388-018-0202.
    >> Share

    March 2018
  223. ZHANG Z, Lin G, Yan Y, Li X, et al
    Transmembrane TNF-alpha promotes chemoresistance in breast cancer cells.
    Oncogene. 2018 Mar 21. pii: 10.1038/s41388-018-0221.
    >> Share

  224. LIU X, Bi L, Wang Q, Wen M, et al
    miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast cancer.
    Oncogene. 2018 Mar 20. pii: 10.1038/s41388-018-0215.
    >> Share

  225. WANG S, Zou Z, Luo X, Mi Y, et al
    LRH1 enhances cell resistance to chemotherapy by transcriptionally activating MDC1 expression and attenuating DNA damage in human breast cancer.
    Oncogene. 2018 Mar 16. pii: 10.1038/s41388-018-0193.
    >> Share

  226. STEBBING J, Shah K, Lit LC, Gagliano T, et al
    LMTK3 confers chemo-resistance in breast cancer.
    Oncogene. 2018 Mar 15. pii: 10.1038/s41388-018-0197.
    >> Share

  227. KIM S, Lee E, Jung J, Lee JW, et al
    microRNA-155 positively regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast cancer.
    Oncogene. 2018 Mar 12. pii: 10.1038/s41388-018-0124.
    >> Share

    February 2018
  228. HE H, Sinha I, Fan R, Haldosen LA, et al
    c-Jun/AP-1 overexpression reprograms ERalpha signaling related to tamoxifen response in ERalpha-positive breast cancer.
    Oncogene. 2018 Feb 22. pii: 10.1038/s41388-018-0165.
    >> Share

  229. SIRKISOON SR, Carpenter RL, Rimkus T, Anderson A, et al
    Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer.
    Oncogene. 2018 Feb 16. pii: 10.1038/s41388-018-0132.
    >> Share

  230. SAATCI O, Borgoni S, Akbulut O, Durmus S, et al
    Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer.
    Oncogene. 2018 Feb 2. pii: 10.1038/s41388-017-0108.
    >> Share

    January 2018
  231. IRELAND L, Santos A, Campbell F, Figueiredo C, et al
    Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer.
    Oncogene. 2018 Jan 25. pii: 10.1038/s41388-017-0115.
    >> Share

  232. BROWNE AL, Charmsaz S, Vareslija D, Fagan A, et al
    Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer.
    Oncogene. 2018 Jan 25. pii: 10.1038/s41388-017-0042.
    >> Share

  233. LIANG H, Xiao J, Zhou Z, Wu J, et al
    Hypoxia induces miR-153 through the IRE1alpha-XBP1 pathway to fine tune the HIF1alpha/VEGFA axis in breast cancer angiogenesis.
    Oncogene. 2018 Jan 25. pii: 10.1038/s41388-017-0089.
    >> Share

  234. LIAO Y, Xia X, Liu N, Cai J, et al
    Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination.
    Oncogene. 2018 Jan 22. pii: 10.1038/s41388-017-0069.
    >> Share

  235. ZHANG Y, Wester L, He J, Geiger T, et al
    IGF1R signaling drives antiestrogen resistance through PAK2/PIX activation in luminal breast cancer.
    Oncogene. 2018 Jan 22. pii: 10.1038/s41388-017-0027.
    >> Share

  236. NAVANEETHAKRISHNAN S, Rosales JL, Lee KY
    Loss of Cdk5 in breast cancer cells promotes ROS-mediated cell death through dysregulation of the mitochondrial permeability transition pore.
    Oncogene. 2018 Jan 19. pii: 10.1038/s41388-017-0103.
    >> Share

  237. LEE GH, Yoo KC, An Y, Lee HJ, et al
    FYN promotes mesenchymal phenotypes of basal type breast cancer cells through STAT5/NOTCH2 signaling node.
    Oncogene. 2018 Jan 19. pii: 10.1038/s41388-017-0114.
    >> Share

  238. IKINK GJ, Boer M, Bakker ERM, Vendel-Zwaagstra A, et al
    Insertional mutagenesis in a HER2-positive breast cancer model reveals ERAS as a driver of cancer and therapy resistance.
    Oncogene. 2018 Jan 12. pii: 10.1038/s41388-017-0031.
    >> Share

  239. MARTINEZ-ORDONEZ A, Seoane S, Cabezas P, Eiro N, et al
    Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis.
    Oncogene. 2018 Jan 11. pii: 10.1038/s41388-017-0036.
    >> Share

  240. MORATH I, Jung C, Leveque R, Linfeng C, et al
    Differential recruitment of CD44 isoforms by ErbB ligands reveals an involvement of CD44 in breast cancer.
    Oncogene. 2018 Jan 11. pii: 10.1038/s41388-017-0030.
    >> Share

    December 2017
  241. PENG F, Wang JH, Fan WJ, Meng YT, et al
    Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia.
    Oncogene. 2017 Dec 18. pii: onc2017407. doi: 10.1038/onc.2017.
    >> Share

  242. HOWLEY BV, Link LA, Grelet S, El-Sabban M, et al
    A CREB3-regulated ER-Golgi trafficking signature promotes metastatic progression in breast cancer.
    Oncogene. 2017 Dec 18. pii: 10.1038/s41388-017-0023.
    >> Share

  243. HAN B, Zhou B, Qu Y, Gao B, et al
    FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness in triple-negative breast cancer.
    Oncogene. 2017 Dec 18. pii: 10.1038/s41388-017-0021.
    >> Share

  244. LUSTIG LC, Dingar D, Tu WB, Lourenco C, et al
    Inhibiting MYC binding to the E-box DNA motif by ME47 decreases tumour xenograft growth.
    Oncogene. 2017;36:6830-6837.
    >> Share

    November 2017
  245. PENG F, Wang JH, Fan WJ, Meng YT, et al
    Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia.
    Oncogene. 2017 Nov 6. doi: 10.1038/onc.2017.
    >> Share

    October 2017
  246. LANGER EM, Kendsersky ND, Daniel CJ, Kuziel GM, et al
    ZEB1-repressed microRNAs inhibit autocrine signaling that promotes vascular mimicry of breast cancer cells.
    Oncogene. 2017 Oct 30. doi: 10.1038/onc.2017.
    >> Share

  247. KNOPFOVA L, Biglieri E, Volodko N, Masarik M, et al
    Transcription factor c-Myb inhibits breast cancer lung metastasis by suppression of tumor cell seeding.
    Oncogene. 2017 Oct 30. doi: 10.1038/onc.2017.
    >> Share

  248. LUCANUS AJ, Yip GW
    Kinesin superfamily: roles in breast cancer, patient prognosis and therapeutics.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    >> Share

  249. WANG CH, Wang PJ, Hsieh YC, Lo S, et al
    Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness properties.
    Oncogene. 2017 Oct 9. doi: 10.1038/onc.2017.
    >> Share

    September 2017
  250. XIA L, Xiao X, Liu WL, Song Y, et al
    Coactosin-like protein CLP/Cotl1 suppresses breast cancer growth through activation of IL-24/PERP and inhibition of non-canonical TGFbeta signaling.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    >> Share

  251. YAMAGUCHI H, Du Y, Nakai K, Ding M, et al
    EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    >> Share

  252. ROWSON-HODEL AR, Wald JH, Hatakeyama J, O'Neal WK, et al
    Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer.
    Oncogene. 2017 Sep 11. doi: 10.1038/onc.2017.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016